{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-15",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "49035-907",
      "marketing_end_date": "20270831",
      "generic_name": "Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl",
      "labeler_name": "Wal-Mart Stores Inc",
      "brand_name": "Equate Severe Cold Multi Symptom",
      "active_ingredients": [
        {
          "name": "ACETAMINOPHEN",
          "strength": "500 mg/1"
        },
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "20 mg/1"
        },
        {
          "name": "PHENYLEPHRINE HYDROCHLORIDE",
          "strength": "10 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "49035-907-91",
          "description": "6 PACKET in 1 CARTON (49035-907-91)  / 1 POWDER, FOR SOLUTION in 1 PACKET",
          "marketing_start_date": "20160718",
          "marketing_end_date": "20270831",
          "sample": false
        }
      ],
      "openfda": {},
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "POWDER, FOR SOLUTION",
      "spl_id": "5bb327e2-5195-2d1c-e063-6394a90a5dff",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20160718",
      "product_id": "49035-907_5bb327e2-5195-2d1c-e063-6394a90a5dff",
      "application_number": "M012",
      "brand_name_base": "Equate Severe Cold Multi Symptom",
      "pharm_class": [
        "Adrenergic alpha1-Agonists [MoA]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]",
        "alpha-1 Adrenergic Agonist [EPC]"
      ]
    }
  ]
}